3 of the very best ASX shares to buy now

These shares are highly rated by the team at Bell Potter for a reason.

| More on:
Happy shareholders clap and smile as they listen to a company earnings report.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX.

Analysts at Bell Potter have recently named a select group of ASX shares they believe represent the very best opportunities on the market right now.

Here are three of Bell Potter's top-rated shares to buy now — and why they're backed to outperform.

James Hardie Industries plc (ASX: JHX)

The first ASX share that could be a best buy according to Bell Potter is James Hardie. It is the dominant player in fibre cement and internal lining solutions — and it is particularly well positioned in the U.S. residential market, where a structural shift is taking place away from timber and vinyl towards more durable and lower-maintenance options like fibre cement.

Bell Potter believes this macro trend is set to continue, giving James Hardie a powerful multi-year tailwind. Following a recent pullback in the share price, the broker sees a compelling buying opportunity. It commented:

In our view, JHX is poised for continued earnings expansion, driven by the structural shift towards fibre cement in the US. Households in the US continue to shift to fibre cement cladding from vinyl/timber, providing a multi-year runway for JHX's revenue and profit growth.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix is quickly establishing itself as one of the most promising ASX healthcare shares. The company has successfully commercialised Illuccix, a prostate cancer imaging agent, and has multiple product launches and clinical trial readouts expected over the next two years.

The broker sees Telix as uniquely positioned in the growing field of radiopharmaceuticals, where demand for precision diagnostics and targeted therapies is accelerating. It also points to Telix's strong earnings growth outlook and attractive valuation. It said:

Valuations are attractive, with 12MF P/E now at 41x, supported by a 2yr EPS CAGR of 44%.

WiseTech Global Ltd (ASX: WTC)

A third ASX share that could be a best buy is WiseTech Global. It is the dominant force in global freight forwarding software. Its flagship CargoWise platform is mission-critical for some of the world's biggest logistics players, offering integration, automation, and efficiency at scale.

Bell Potter sees ongoing growth through both organic expansion and strategic acquisitions, with the company set to benefit from global supply chain digitisation and further product rollouts. The broker said:

WTC is a growth story with strategic acquisitions representing upside potential enabling WTC to benefit from large-scale global rollouts and consolidation within the logistics sector.

Should you invest $1,000 in Dicker Data right now?

Before you buy Dicker Data shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Dicker Data wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor James Mickleboro has positions in WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Bell Potter names the best dirt cheap ASX 200 stocks to buy

These top stocks could be going cheap according to the broker.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

man sitting in hammock on beach representing asx shares to buy for retirement
Broker Notes

Want to retire rich? These ASX 200 shares could be top buy and hold picks

Analysts think these shares could be great long term options for Aussie investors.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Goldman Sachs says this ASX 200 share is dirt cheap

The broker sees big returns on the cards for buyers of this stock.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Goldman Sachs says this ASX 200 share could rocket almost 100%!

Let's see why the broker is so bullish on this cheap stock.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares could rise 30% to 70%

Analysts think these shares could be destined to deliver big returns over the next 12 months.

Read more »